Ignite Creation Date:
2025-12-24 @ 3:17 PM
Ignite Modification Date:
2025-12-25 @ 7:32 PM
Study NCT ID:
NCT00757692
Status:
COMPLETED
Last Update Posted:
2013-02-20
First Post:
2008-09-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer.
Sponsor:
British Columbia Cancer Agency
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-01
Start Date Type:
None
Primary Completion Date:
2012-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-11
Completion Date Type:
ACTUAL
First Submit Date:
2008-09-19
First Submit QC Date:
None
Study First Post Date:
2008-09-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-02-19
Last Update Post Date:
2013-02-20
Last Update Post Date Type:
ESTIMATED